Skip to content

Impact of glycopyrrolate on visual field during AFOI: a multi-center, double-blind, non-Inferiority, randomized controlled study

Impact of glycopyrrolate on visual field during AFOI

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086581
Enrollment
Unknown
Registered
2024-07-05
Start date
2024-07-05
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with predictable difficult airway

Interventions

Experimental group:Normal saline
Control group:glycopyrrolate

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with expected difficult airway for awake flexible endoscopic endotracheal intubation; 2. Age>=18 years old; 3. American Society of Anesthesiologists (ASA) grade I-III.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to glycopyrronium and its constituent components; 2. Patients with a history of angle-closure glaucoma, myasthenia gravis, paralytic intestinal obstruction, pyloric stenosis, and prostate hypertrophy; 3. Patients with severe liver and kidney insufficiency; 4. Heart rate > 100 beats/min at rest or severe arrhythmia before surgery; 5. Patients taking anticholinergic drugs (antiparkinson's drugs, tricyclic antidepressants) before surgery; 6. Patients with severe hypertension and coronary heart disease; 7. Patients with salivary gland secretion disorders; 8. Patients with a mouth opening < 1cm; 9. Patients who refuse to participate in this study and sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Grading of oropharyngeal secretions;

Secondary

MeasureTime frame
One-time intubation success rate;Overall intubation success rate;The time of the AFOI;Incidence of hypoxia during AFOI;Changes in blood pressure and heart rate during AFOI;Incidence of adverse events during AFOI;

Countries

China

Contacts

Public ContactWenxian Li

Eye & ENT Hospital, Fudan University

liwenxian@eentanesthesia.com+86 139 1742 6838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026